Our mission is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Built with the goal of radically transforming the rate of biomedical discovery and progress, Causaly's AI reads the entire volume of biomedical literature ever published, in seconds. This makes it easy for anyone to run deep searches and find answers to complex research questions that would take weeks, or even months to discover with traditional keyword search. Zero in on the insights you need to make new hypotheses and discoveries.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Yiannis Kiachopoulos

Chief Technical Officer

Artur Saudabayev

Browse more venture capital transactions:

Prev: 7/13/2023: Simbe Robotics venture capital transaction
Next: 7/14/2023: TROES venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary